Search

Your search keyword '"Glaab, E."' showing total 71 results

Search Constraints

Start Over You searched for: Author "Glaab, E." Remove constraint Author: "Glaab, E." Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
71 results on '"Glaab, E."'

Search Results

3. The benefits, costs and feasibility of a low incidence COVID-19 strategy

4. Crowdsourcing digital health measures to predict Parkinson’s disease severity: the Parkinson’s Disease Digital Biomarker DREAM Challenge

5. A rare loss-of-function variant of ADAM17 is associated with late-onset familial Alzheimer disease

6. NeuroChip, an updated version of the NeuroX genotyping platform to rapidly screen for variants associated with neurological diseases

9. Bioinformatics approaches for studying molecular sex differences in complex diseases.

10. Integrating digital gait data with metabolomics and clinical data to predict outcomes in Parkinson's disease.

11. Converging peripheral blood microRNA profiles in Parkinson's disease and progressive supranuclear palsy.

12. Progression subtypes in Parkinson's disease identified by a data-driven multi cohort analysis.

13. Comprehensive blood metabolomics profiling of Parkinson's disease reveals coordinated alterations in xanthine metabolism.

14. Single cell transcriptome analysis of the THY-Tau22 mouse model of Alzheimer's disease reveals sex-dependent dysregulations.

15. Luxembourg Parkinson's study -comprehensive baseline analysis of Parkinson's disease and atypical parkinsonism.

16. Impaired neuron differentiation in GBA-associated Parkinson's disease is linked to cell cycle defects in organoids.

17. Penalized regression with multiple sources of prior effects.

18. Omics data integration suggests a potential idiopathic Parkinson's disease signature.

19. Comparison of two protocols for the generation of iPSC-derived human astrocytes.

20. Predicting dichotomised outcomes from high-dimensional data in biomedicine.

21. Results and lessons learned from the sbv IMPROVER metagenomics diagnostics for inflammatory bowel disease challenge.

22. Systems level analysis of sex-dependent gene expression changes in Parkinson's disease.

23. RvD1 n-3 DPA Downregulates the Transcription of Pro-Inflammatory Genes in Oral Epithelial Cells and Reverses Nuclear Translocation of Transcription Factor p65 after TNF-α Stimulation.

25. Generation of isogenic control DJ-1-delP GC13 for the genetic Parkinson's disease-patient derived iPSC line DJ-1-delP (LCSBi008-A-1).

26. Leveraging the Potential of Digital Technology for Better Individualized Treatment of Parkinson's Disease.

27. The benefits, costs and feasibility of a low incidence COVID-19 strategy.

28. Biomarker discovery studies for patient stratification using machine learning analysis of omics data: a scoping review.

29. COVID-19 Disease Map, a computational knowledge repository of virus-host interaction mechanisms.

30. Predicting correlated outcomes from molecular data.

31. iPSC-Derived Microglia as a Model to Study Inflammation in Idiopathic Parkinson's Disease.

32. COVID19 Disease Map, a computational knowledge repository of virus-host interaction mechanisms.

33. A look into the future of the COVID-19 pandemic in Europe: an expert consultation.

34. Predictive and interpretable models via the stacked elastic net.

35. Characterization of DNA Methylomic Signatures in Induced Pluripotent Stem Cells During Neuronal Differentiation.

36. Gene selection for optimal prediction of cell position in tissues from single-cell transcriptomics data.

37. Non-Coding RNAs in the Brain-Heart Axis: The Case of Parkinson's Disease.

38. Comparative transcriptome analysis of Parkinson's disease and Hutchinson-Gilford progeria syndrome reveals shared susceptible cellular network processes.

39. Variants in Miro1 Cause Alterations of ER-Mitochondria Contact Sites in Fibroblasts from Parkinson's Disease Patients.

40. Integrated Analyses of Microbiome and Longitudinal Metabolome Data Reveal Microbial-Host Interactions on Sulfur Metabolism in Parkinson's Disease.

41. Transcriptome profiling data reveals ubiquitin-specific peptidase 9 knockdown effects.

42. BSA4Yeast: Web-based quantitative trait locus linkage analysis and bulk segregant analysis of yeast sequencing data.

43. 3D Cultures of Parkinson's Disease-Specific Dopaminergic Neurons for High Content Phenotyping and Drug Testing.

44. Metformin reverses TRAP1 mutation-associated alterations in mitochondrial function in Parkinson's disease.

45. Molecular Identification of d-Ribulokinase in Budding Yeast and Mammals.

47. Conversion of Nonproliferating Astrocytes into Neurogenic Neural Stem Cells: Control by FGF2 and Interferon-γ.

48. A microfluidics-based in vitro model of the gastrointestinal human-microbe interface.

49. Using prior knowledge from cellular pathways and molecular networks for diagnostic specimen classification.

50. Building a virtual ligand screening pipeline using free software: a survey.

Catalog

Books, media, physical & digital resources